BREAST CANCER; HER2-POSITIVE; METASTATIC

Clinical trials for BREAST CANCER; HER2-POSITIVE; METASTATIC explained in plain language.

Never miss a new study

Get alerted when new BREAST CANCER; HER2-POSITIVE; METASTATIC trials appear

Sign up with your email to follow new studies for BREAST CANCER; HER2-POSITIVE; METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial tests promising new treatment against aggressive breast cancer

Disease control Ongoing

This large Phase 3 study is comparing new drug combinations against standard treatment for people with advanced HER2-positive breast cancer that has spread. It's testing whether newer targeted drugs can help patients live longer without their cancer getting worse compared to curr…

Matched conditions: BREAST CANCER; HER2-POSITIVE; METASTATIC

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

BREAST CANCER; HER2-POSITIVE; METASTATIC

Get alerted when new BREAST CANCER; HER2-POSITIVE; METASTATIC trials appear

Major trial tests promising new treatment against aggressive breast cancer